AC gas bubbles do not affect corneal endothelial cell density in LASIK procedures

Article

Anterior chamber (AC) gas bubbles do not affect corneal endothelial cell density (ECD) during flap creation in LASIK operations.

Anterior chamber (AC) gas bubbles do not affect corneal endothelial cell density (ECD) during flap creation in LASIK operations, according to a study featured in the European Journal of Ophthalmology.

A team led by Dr Minoru Tomita, Shinagawa LASIK Center, Tokyo, Japan, conducted myopic LASIK in 436 eyes of 252 patients. For flap creation the IntraLase FS30 was used and Akkgretto Wave Eye-Q was used to perform excimer laser ablation. The ECD was measured pre-operatively and 3-month postoperatively. These were measured and compared using a noncontact specular microscope. Changes in ECD were compared to the group that did not have AC gas bubbles.

The study findings demonstrated that the average ECD reduction post-LASIK was –15±102 cells/mm2 for eyes without AC gas bubbles and –35±130 cells/mm2 for eyes with AC gas bubbles. There were no significant changes in ECD between either groups.

It was also concluded that using Intralase FS30 is a safe and successful way to complete LASIK operations and does not damage ECD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.